Design
Case_report
Authors
Loading...
Mandates strict contraindication adherence and daily prothrombin monitoring for dicumarol; leaves open applicability to modern vitamin K antagonists.
Highlights the severe bleeding risks of dicumarol and the absolute necessity of daily prothrombin monitoring and adherence to contraindications.
Ivan F. Duff (1949) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: